Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Exp Clin Transplant ; 15(Suppl 1): 258-260, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28260481

RESUMEN

OBJECTIVES: Our objective was to evaluate the incidence of renal replacement therapy after orthotopic liver transplant and to evaluate and analyze patient outcomes. MATERIALS AND METHODS: We performed a retrospective analysis of 177 consecutive patients at a tertiary care unit who underwent orthotopic liver transplant between January 2010 and June 2016. Patients who were admitted to the intensive care unit after orthotopic liver transplant and who required renal replacement therapy were included. RESULTS: A total of 177 (79 adult, 98 pediatric) orthotopic liver transplants were performed during the study period. Of these, 35 patients (19%) required renal replacement therapy during the early posttransplantation period. After excluding 5 patients with previous chronic renal failure, 30 patients (17%; 20 adult [25% ], 10 pediatric [10% ]) with acute kidney injury required renal replacement therapy. The mean patient age was 31.1 ± 20.0 years, with a mean Model for End-stage Liver Disease score of 16.7 ± 12.3. Of the patients with acute kidney injury who underwent renal replacement therapy, in-hospital mortality was 23.3% (7 of 30 patients), and 40% remained on dialysis. No significant difference was seen in mortality between early versus delayed initiation of renal replacement therapy in patients with stage 3 acute kidney injury (P = .17). CONCLUSIONS: Of liver transplant recipients who present with acute kidney injury, 19% require renal replacement therapy, and in-hospital mortality is 20% in the early postoperative period.


Asunto(s)
Lesión Renal Aguda/epidemiología , Lesión Renal Aguda/terapia , Trasplante de Hígado/efectos adversos , Terapia de Reemplazo Renal , Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/mortalidad , Adolescente , Adulto , Niño , Femenino , Mortalidad Hospitalaria , Humanos , Incidencia , Trasplante de Hígado/mortalidad , Masculino , Persona de Mediana Edad , Terapia de Reemplazo Renal/efectos adversos , Terapia de Reemplazo Renal/mortalidad , Estudios Retrospectivos , Factores de Riesgo , Centros de Atención Terciaria , Factores de Tiempo , Resultado del Tratamiento , Turquía/epidemiología , Adulto Joven
2.
Exp Clin Transplant ; 14(Suppl 3): 121-124, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-27805530

RESUMEN

Heart transplant is the only definitive treatment of end-stage heart failure. Venoarterial extracorporeal membrane oxygenation may be used as a bridge to heart transplant. Among 31 patients who underwent heart transplant between January 2014 and June 2016, we present our experiences with 3 patients who received venoarterial extracorporeal support as a bridge to heart transplant. The first patient was a 51-year-old male with ischemic dilated cardiomyopathy. Transplant was performed after 6 days of extracorporeal support, and the patient was discharged and alive at follow-up. Patient 2 was a 12-yearold girl with dilated cardiomyopathy who presented with cardiac arrest. Extracorporeal support was initiated during cardiopulmonary resuscitation. She had full neurologic recovery and remained on the wait list. She received a transplant 22 days after resuscitation. She survived and was alive at day 220 posttransplant. The third patient was a 50-year-old male with ischemic dilated cardiomyopathy requiring venoarterial extracorporeal support. Percutaneous balloon atrial septostomy was performed for left ventricle venting. He underwent transplant on day 28 after intensive care unit admission. He died 29 days after release from the hospital. Regarding patients on heart transplant wait lists who are worsening despite optimal medical therapy, venoarterial extracorporeal membrane oxygenation support is a safe and viable last resort.


Asunto(s)
Oxigenación por Membrana Extracorpórea , Insuficiencia Cardíaca/terapia , Trasplante de Corazón , Listas de Espera , Cardiomiopatía Dilatada/complicaciones , Cardiomiopatía Dilatada/diagnóstico , Niño , Resultado Fatal , Femenino , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/etiología , Insuficiencia Cardíaca/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Recuperación de la Función , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento
3.
Exp Clin Transplant ; 13 Suppl 3: 44-7, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26640910

RESUMEN

OBJECTIVES: Frequency of pulmonary complications after renal transplant has been reported to range from 3% to 17%. The objective of this study was to evaluate renal transplant recipients admitted to an intensive care unit to identify incidence and cause of acute respiratory failure in the postoperative period and compare clinical features and outcomes between those with and without acute respiratory failure. MATERIALS AND METHODS: We retrospectively screened the data of 540 consecutive adult renal transplant recipients who received their grafts at a single transplant center and included those patients admitted to an intensive care unit during this period for this study. Acute respiratory failure was defined as severe dyspnea, respiratory distress, decreased oxygen saturation, hypoxemia or hypercapnia on room air, or requirement of noninvasive or invasive mechanical ventilation. RESULTS: Among the 540 adult renal transplant recipients, 55 (10.7%) were admitted to an intensive care unit, including 26 (47.3%) admitted for acute respiratory failure. Median time from transplant to intensive care unit admission was 10 months (range, 0-67 mo). The leading causes of acute respiratory failure were bacterial pneumonia (56%) and cardiogenic pulmonary edema (44%). Mean partial pressure of arterial oxygen to fractional inspired oxygen ratio was 174 ± 59, invasive mechanical ventilation was used in 13 patients (50%), and noninvasive mechanical ventilation was used in 8 patients (31%). The overall mortality was 16.4%. CONCLUSIONS: Acute respiratory failure was the reason for intensive care unit admission in almost half of our renal transplant recipients. Main causes of acute respiratory failure were bacterial pneumonia and cardiogenic pulmonary edema. Mortality of patients admitted for acute respiratory failure was similar to those without acute respiratory failure.


Asunto(s)
Unidades de Cuidados Intensivos , Trasplante de Riñón/efectos adversos , Neumonía Bacteriana/etiología , Edema Pulmonar/etiología , Insuficiencia Respiratoria/etiología , Enfermedad Aguda , Adulto , Femenino , Humanos , Trasplante de Riñón/mortalidad , Masculino , Persona de Mediana Edad , Admisión del Paciente , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/mortalidad , Neumonía Bacteriana/terapia , Edema Pulmonar/diagnóstico , Edema Pulmonar/mortalidad , Edema Pulmonar/terapia , Sistema de Registros , Respiración Artificial , Insuficiencia Respiratoria/diagnóstico , Insuficiencia Respiratoria/mortalidad , Insuficiencia Respiratoria/terapia , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento , Turquía
4.
IEEE Trans Syst Man Cybern B Cybern ; 38(1): 155-73, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18293495

RESUMEN

In this paper, we present an extensive study of 3-D face recognition algorithms and examine the benefits of various score-, rank-, and decision-level fusion rules. We investigate face recognizers from two perspectives: the data representation techniques used and the feature extraction algorithms that match best each representation type. We also consider novel applications of various feature extraction techniques such as discrete Fourier transform, discrete cosine transform, nonnegative matrix factorization, and principal curvature directions to the shape modality. We discuss and compare various classifier combination methods such as fixed rules voting- and rank-based fusion schemes. We also present a dynamic confidence estimation algorithm to boost fusion performance. In identification experiments performed on FRGC v1.0 and FRGC v2.0 face databases, we tried to find the answers to the following questions: 1) the relative importance of the face representation technique vis-à-vis the types of features extracted; 2) the impact of the gallery size; 3) the conditions, under which subspace methods are preferable, and the compression factor; 4) the most advantageous fusion level and fusion methods; 5) the role confidence votes in improving fusion and the style of selecting experts in the fusion; and 6) the consistency of the conclusions across different databases.


Asunto(s)
Inteligencia Artificial , Biometría/métodos , Cara/anatomía & histología , Interpretación de Imagen Asistida por Computador/métodos , Imagenología Tridimensional/métodos , Reconocimiento de Normas Patrones Automatizadas/métodos , Técnica de Sustracción , Algoritmos , Humanos , Aumento de la Imagen/métodos , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA